Primary  	Primary  	 JJ	B-NP
angiitis  	angiitis  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
central  	central  	 JJ	O
nervous  	nervous  	 JJ	O
system  	system  	 NN	O
Primary  	Primary  	 JJ	B-NP
angiitis  	angiitis  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
central  	central  	 JJ	I-NP
nervous  	nervous  	 JJ	I-NP
system  	system  	 NN	I-NP
( 	( 	 -LRB-	O
PACNS 	PACNS 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
first  	first  	 RB	O
identified  	identified  	 VBN	O
half  	half  	 PDT	O
a  	a  	 DT	O
century  	century  	 NN	O
ago 	ago 	 RB	O
,  	,  	 ,	O
but  	but  	 CC	O
it  	it  	 PRP	O
remains  	remains  	 VBZ	O
a  	a  	 DT	O
rare  	rare  	 JJ	O
and  	and  	 CC	O
challenging  	challenging  	 JJ	O
disease 	disease 	 NN	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
important  	important  	 JJ	O
advances  	advances  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
made  	made  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
field  	field  	 NN	O
of  	of  	 IN	O
PACNS 	PACNS 	 NNP	B-NP
,  	,  	 ,	O
mainly  	mainly  	 RB	O
through  	through  	 IN	O
recently  	recently  	 RB	O
published  	published  	 VBN	O
retrospective  	retrospective  	 JJ	B-NP
analyses  	analyses  	 NNS	I-NP
of  	of  	 IN	O
large  	large  	 JJ	O
groups  	groups  	 NNS	O
of  	of  	 IN	O
PACNS  	PACNS  	 NNP	B-NP
patients 	patients 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
consideration  	consideration  	 NN	B-NP
of  	of  	 IN	O
reversible  	reversible  	 JJ	O
cerebral  	cerebral  	 JJ	B-NP
vasoconstriction  	vasoconstriction  	 JJ	I-NP
syndrome  	syndrome  	 NN	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
distinct  	distinct  	 JJ	O
entity 	entity 	 NN	O
.  	.  	 .	O
Clinical  	Clinical  	 JJ	B-NP
manifestations  	manifestations  	 NNS	I-NP
of  	of  	 IN	I-NP
PACNS  	PACNS  	 NNP	I-NP
are  	are  	 VBP	O
variable  	variable  	 JJ	O
and  	and  	 CC	O
non-specific 	non-specific 	 JJ	B-NP
.  	.  	 .	O
Even  	Even  	 RB	O
though  	though  	 IN	O
neuroimaging  	neuroimaging  	 NNS	B-NP
can  	can  	 MD	O
be  	be  	 VB	O
suggestive  	suggestive  	 VBN	O
of  	of  	 IN	O
vasculitis 	vasculitis 	 NN	B-NP
,  	,  	 ,	O
only  	only  	 RB	O
a  	a  	 DT	O
leptomeningeal  	leptomeningeal  	 JJ	B-NP
biopsy  	biopsy  	 NN	I-NP
can  	can  	 MD	O
definitively  	definitively  	 RB	O
confirm  	confirm  	 VB	O
vasculitis 	vasculitis 	 NNS	B-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
brain  	brain  	 NN	O
sample  	sample  	 NN	O
is  	is  	 VBZ	O
taken  	taken  	 VBN	O
in  	in  	 IN	O
less  	less  	 JJR	O
than  	than  	 IN	O
half  	half  	 PDT	O
the  	the  	 DT	O
patients  	patients  	 NNS	O
and  	and  	 CC	O
cannot  	cannot  	 JJ	O
further  	further  	 JJ	O
help  	help  	 NN	O
to  	to  	 TO	O
distinguish  	distinguish  	 VB	O
between  	between  	 IN	O
PACNS  	PACNS  	 NNP	B-NP
and  	and  	 CC	O
secondary  	secondary  	 JJ	B-NP
vasculitis  	vasculitis  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
central  	central  	 JJ	O
nervous  	nervous  	 JJ	O
system 	system 	 NN	O
.  	.  	 .	O
Hence 	Hence 	 RB	O
,  	,  	 ,	O
physicians  	physicians  	 NNS	O
should  	should  	 MD	O
be  	be  	 VB	O
aware  	aware  	 JJ	O
of  	of  	 IN	O
all  	all  	 DT	O
alternative  	alternative  	 JJ	O
diagnoses  	diagnoses  	 NN	O
and  	and  	 CC	O
PACNS  	PACNS  	 NNP	B-NP
mimickers 	mimickers 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
are  	are  	 VBP	O
now  	now  	 RB	O
well-known 	well-known 	 JJ	O
.  	.  	 .	O
Whereas  	Whereas  	 IN	O
prognosis  	prognosis  	 VBG	O
now  	now  	 RB	O
appears  	appears  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
much  	much  	 RB	O
better  	better  	 JJR	O
than  	than  	 IN	O
for  	for  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
reported  	reported  	 JJ	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
probably  	probably  	 RB	O
attributable  	attributable  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
corticosteroids  	corticosteroids  	 NN	B-NP
and  	and  	 CC	O
immunosuppressants 	immunosuppressants 	 NN	B-NP
,  	,  	 ,	O
mainly  	mainly  	 RB	O
cyclophosphamide 	cyclophosphamide 	 JJ	O
,  	,  	 ,	O
the  	the  	 DT	O
optimal  	optimal  	 JJ	B-NP
therapeutic  	therapeutic  	 JJ	I-NP
regimen 	regimen 	 NN	I-NP
,  	,  	 ,	O
potentially  	potentially  	 RB	O
based  	based  	 VBN	O
on  	on  	 IN	O
each  	each  	 DT	O
patient 	patient 	 NN	O
's  	's  	 POS	O
characteristics 	characteristics 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
its  	its  	 PRP$	O
duration  	duration  	 NNS	O
remain  	remain  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
determined 	determined 	 VBN	O
.  	.  	 .	O
Only  	Only  	 RB	O
multicenter  	multicenter  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
and  	and  	 CC	O
prospective  	prospective  	 JJ	B-NP
therapeutic  	therapeutic  	 JJ	I-NP
trials  	trials  	 NNS	I-NP
will  	will  	 MD	O
be  	be  	 VB	O
able  	able  	 JJ	O
to  	to  	 TO	O
clarify  	clarify  	 VB	O
these  	these  	 DT	O
issues  	issues  	 NNS	O
on  	on  	 IN	O
therapy  	therapy  	 NN	O
and  	and  	 CC	O
eventually  	eventually  	 RB	O
provide  	provide  	 VB	O
some  	some  	 DT	O
data  	data  	 NNS	O
on  	on  	 IN	O
PACNS  	PACNS  	 NNP	B-NP
physiopathogenesis 	physiopathogenesis 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
remains  	remains  	 VBZ	O
a  	a  	 DT	O
poorly  	poorly  	 RB	O
explored  	explored  	 JJ	O
domain 	domain 	 NN	O
.  	.  	 .	O
